IM Cannabis Corp ( (TSE:IMCC) ) has issued an update.
IM Cannabis Corp. announced it will report its fourth quarter and full year 2024 financial results on March 31, 2025. The company will host a Zoom web conference to discuss the results, followed by a Q&A session for investors. This announcement highlights IMC’s ongoing commitment to transparency and engagement with its stakeholders, potentially impacting investor confidence and market positioning.
More about IM Cannabis Corp
IM Cannabis Corp. is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The company focuses on sustainable and profitable growth in these high-value markets, leveraging a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. IMC operates in Israel through its relationship with Focus Medical Herbs Ltd., and in Germany through Adjupharm GmbH, distributing cannabis to pharmacies for medical patients.
YTD Price Performance: -26.75%
Average Trading Volume: 12,885
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $5.38M
See more insights into IMCC stock on TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com